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Under Siege: Minireview
The Brain on Opiates
Eric J. Nestler and dependence, at least in in vivo systems. The recent
cloning of these receptors hasenabled more penetratingLaboratory of Molecular Psychiatry
Yale University School of Medicine analyses (Mansour et al., 1995), which could yet reveal
alterations related to opiate addiction. For example, ex-New Haven, Connecticut 06508
posure to agonist in vitro elicits receptor desensitization
and down-regulation, which could be related to aspectsMany of the terms used in the addiction field today were
developed originally based on the opiates, one of the of tolerance in vivo (e.g., Harris and Williams, 1991; Von
Zastrow et al., 1994).oldest and best characterized classes of abused drugs.
Tolerance describes the need for an increasing dose of In contrast with the lack of evidence for a role of
adaptations in opioid peptides and receptors in opiateopiate to achieve the same effect; this term was based
originally on the tolerance that develops to many of addiction, considerable evidence has implicated a role
for postreceptor, intracellular messenger pathways.the acute behavioral actions of opiates (e.g., analgesia,
autonomic inhibition, and ªhighº). Dependence de- Chronic exposure to opiates has been shown to elicit
adaptations in some of the same intracellular pathwaysscribes an altered physiological state caused by re-
peated opiate exposure such that cessation of drug that mediate the acute actions of the drugs. Moreover,
such adaptations have been related to tolerance andadministration leads to a withdrawal syndrome charac-
terized by serious physiological disturbances. This term dependence phenomena that can be demonstrated at
the level of individual neurons.was used originally to describe physical opiate depen-
dence as characterized by classical opiate withdrawal Studies of the Locus Coeruleus
The locus coeruleus (LC), the major noradrenergic nu-(i.e., ªcold turkeyº). More recently, it has become clear
that opiates also result in a psychological form of depen- cleus in brain, is located in the brain stem and involved
in control of autonomic function and attentional states.dence, which results in emotional or motivational symp-
toms upon drug withdrawal. This latter form of depen- Activation of this brain region, and the resulting increase
in noradrenergic innervation of large regions of the braindence is probably the strongest determinant of opiate
addiction, which can be defined as compulsive drug and spinal cord, is one of the major determinants of
physical opiate withdrawal (Koob et al., 1992; Nestler etcraving and administration despite horrendous adverse
consequences. al., 1993, 1994). Since LC neurons are extremely well
characterized electrophysiologically, and are clusteredThe classical distinction between physical and psy-
chological forms of dependence maps onto partially dis- in a densely packed, relatively homogeneous nucleus,
they have served as a useful model of opiate action.tinct regions of the CNS that underlie these phenomena
(Koob, 1992). The analgesic and autonomic effects of Acutely, opiates, acting at m receptors, inhibit LC neu-
rons in part by activating an inward rectifying K1 currentopiates, and the bulk of physical withdrawal symptoms,
have been ascribed largely to drug action in the brain through coupling with the Gi/o family of G proteins (Figure
1). Opiate inhibition is also achieved by inhibiting anstem and spinal cord. In contrast, the acute rewarding
effects of opiates, and the motivational symptoms of inward nonspecific cation current, an effect mediated
via inhibition of adenylyl cyclase and reduced activitywithdrawal, have been ascribed largely to the mesolim-
bic dopamine system and other limbic structures (e.g., of protein kinase A (PKA) (Alreja and Aghajanian, 1993).
The channel or pump responsible for this current hasamygdala and hippocampus; Koob, 1992; Wise, 1990).
Identification of specific neural circuits responsible for not yet been identified, so it remains to be established
whether PKA phosphorylates the pump or channel di-various actions of opiates has made it possible to begin
the process of identifying the relevant molecular and rectly. LC neurons develop cellular forms of tolerance
and dependence; in the continued presence of opiates,cellular events that underlie the altered functioning of
these circuits. LC neurons gradually recover from the acute inhibitory
effect of the drug, whereas upon removal of the drug,
LC neurons show a manyfold activation above controlCellular and Molecular Adaptations Underlying
levels (for review, see Nestler et al., 1994).Opiate Tolerance and Dependence
We now know that these changes are mediated inThe discovery of endogenous opioid peptides and opi-
part by an up-regulation of the cAMP pathway inducedoid receptors over twenty years ago led to the expecta-
by chronic exposure to opiates. Thus, chronic opiatetion that adaptations in these proteins in response to
administration increases levels of expression of adenylylrepeated opiate exposure underlie many features of opi-
cyclase and PKA in the LC (Nestler et al., 1993, 1994;ate addiction. While investigation of the opioid peptides
Matsuoka et al., 1994), adaptations that increase theenkephalin, endorphin, and dynorphin has revealed a
intrinsic excitability of the neurons via activation of thegreat deal about peptide neurotransmitters in general
nonspecific cation current. In the chronic-treated state,and a role for the opioid peptides in stress-related phe-
the combined presence of the up-regulated cAMP path-nomena (Olsen et al., 1994), adaptations in the expres-
way and of the opiate helps return LC neurons to theirsion of peptides themselves have not provided compel-
normal firing rates. Upon removal of the opiate, the up-ling models for opiate tolerance or dependence.
regulated cAMP pathway is unopposed and contributesSimilarly, early studies of opiate regulation of the three
types of opioid receptor, m, d, and k, by use of radioli- to the activation of LC neurons during withdrawal.
Additional mechanisms are likely to be involved ingand binding assays failed to explain opiate tolerance
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is reduced (Sim et al., 1996). Finally, regulation of the
K1 channels themselves has been implicated (Kovoor
et al., 1995).
The mechanism by which chronic opiate exposure
leads to up-regulation of the cAMP pathway in LC neu-
rons is the focus of ongoing investigation. One model,
depicted in Figure 1, proposes a role for the transcription
factor cAMP response element±binding protein (CREB).
Levels of CREBare increased in the LC following chronic
morphine administration (Widnell et al., 1994). This
raises the possibility that increases in CREB contribute
to up-regulation of the other cAMP pathway proteins
and thereby to the effects of chronic opiates on the
electrophysiological state of LC neurons and their be-
havioral manifestations. The current challenge is to
study this possibility directly. For example, intra-LC ad-
ministration of antisense oligonucleotides to CREB, or
genetic mutant mice deficient in CREB, would be ex-
pected to show diminished effects of chronic opiates
in the LC, whereas viral-mediated increases in CREB
expression in this brain region would be expected to
mimic some of the effects of chronic opiates. Work along
these lines is underway in several laboratories.
Activation of the LC during opiate withdrawal also
depends upon factors extrinsic to the LC, namely an
Figure 1. Scheme Illustrating Opiate Actions in the LC increase in glutamatergic neurotransmission to the
Opiates acutely inhibit LC neurons by increasing the conductance LC from the medullary nucleus paragigantocellularis
of a K1 channel (light cross-hatch) via coupling with subtypes of Gi (Akaoka et al., 1991; Nestler et al., 1994). The factors that
and/or Go and by decreasing a Na1-dependent inward current (dark drive this activation of the paragigantocellularis remaincross-hatch) via coupling with Gi/o and the consequent inhibition of
unknown, but appear to involve several medullary andadenylyl cyclase. Reduced levels of cAMP decrease PKA activity
spinal nuclei. Up-regulation of the cAMP pathway, whichand the phosphorylation of the responsible channel or pump. Inhibi-
tionof the cAMP pathway also decreases phosphorylation of numer- occurs in some of these regions, may be one of the
ous other proteins and thereby affects many additional processes mechanisms responsible for activation of theseproximal
in the neuron. For example, it reduces the phosphorylation state of neural circuits. However, it should be emphasized that
CREB, which may initiate some of the longer-term changes in LC
up-regulation of the cAMP pathway is probably one offunction. Upward bold arrows summarize the effects of chronic
many molecular adaptations responsible for opiate tol-morphine in the LC. Chronic morphine increases levels of adenylyl
erance and dependence at the cellular level (Childers,cyclase, PKA, and several phosphoproteins, including CREB. These
changes contribute to the altered phenotype of the drug-addicted 1991).
state. For example, the intrinsic excitability of LC neurons is in-
creased via enhanced activity of the cAMP pathway and Na1-depen-
dent inward current, which contributes to the tolerance, depen- Motivational Dependence and the Mesolimbic
dence, and withdrawal exhibited by these neurons. This altered
Dopamine Systemphenotypic state may be maintained in part by up-regulation of
As mentioned above, the mesolimbic dopamine systemCREB expression.
plays an important role in acute opiate reinforcement
and the changes in reinforcement mechanisms that
characterize addiction. This neural system consists oftolerance in LC neurons, since up-regulation of the
cAMP pathway would not appear to explain the dimin- dopaminergic neurons in the ventral tegmental area
(VTA) and the limbic brain regions to which they project,ished ability of opiate agonists to activate K1 channels,
which occurs independently of this pathway. Several such as the nucleus accumbens (NAc) and prefrontal
cortex.possibilities exist but have yet to be directly implicated
in the LC or another in vivo system. Opioid receptors The mesolimbic dopamine system is thought to regu-
late motivational behavior to natural reinforcers suchmay be functionally uncoupled from their G proteins,
perhaps through phosphorylation of the receptors or G as food and sex. The changes that chronic opiate expo-
sure elicits in the VTA and NAc that are responsibleprotein subunits. For example, opioid receptors can be
desensitized upon phosphorylation by G protein recep- for motivational dependence remain poorly understood.
Acutely, opiates increase dopaminergic signals to thetor kinases (e.g., bARK; Pei et al., 1995), and such ki-
nases are up-regulated in the LC following chronic mor- NAc via activation of VTA dopamine neurons. This acti-
vation occurs indirectly through inhibition of inhibitoryphine treatment (Nestler et al., 1994). Opiate-induced
down-regulation of Gi/oa subunits, which has been ob- GABAergic interneurons in the VTA (Johnson and North,
1992). Opiates also directly affect NAc neurons indepen-served in several neuronal cell types, could also be in-
volved. Although Gi/oa immunoreactivity in the LC is in- dently of dopamine via activation of opioid receptors
expressed by these neurons. The relative contribution ofcreased by chronic morphine exposure, the functioning
of the proteins, based on measures of GTPase activity, these two sites of opiate action to the acute reinforcing
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action elsewhere, adaptations in intracellular signaling
pathways have been illuminating.
Up-Regulation of the cAMP Pathway in the NAc
Chronic morphine treatment increases levels of adenylyl
cyclase and PKA in the NAc, as observed in the LC
(Nestler et al., 1993; Self and Nestler, 1995). There is
also a reduction in levels of Gi/oa subunits, which would
further increase cAMP function. Similar effects are seen
upon chronic self-administration of heroin or chronic
exposure to other drugs of abuse. Up-regulation of the
cAMP pathway has been related directly to the acute
reinforcing effects of opiates. Direct administration of
agents into the NAc that inhibit Gi/o or activate protein
kinase reduces the acute reinforcing effects of opiates
(Self et al., 1994; Self and Nestler, 1995). Agents that
produce the opposite effect potentiate opiate reinforce-
ment. These findings are consistent with the view that
up-regulation of the cAMP pathway that occurs in re-
sponse to chronic opiate exposure could be one mecha-
nism of tolerance and dependence to the motivational
effects of opiates (Figure 2); this adaptation would op-
pose acute opiate reinforcement as well as lead to an
aversive motivational state during opiate withdrawal.
One of the challenges in delineating the functionalFigure 2. Scheme Illustrating Changes in Mesolimbic Dopamine
consequences of molecular adaptations in the NAc isFunction Associated with Opiate Addiction
the complexity of this brain region and its afferent and(A) VTA neuron projecting to an NAc neuron under normal condi-
efferent connections. Unlike the LC, the NAc containstions. (B) The same neurons after chronic opiate exposure. Acutely,
opiates produce potent effects both in the VTA and in the NAc. After several types of neurons that may well play very different
chronic exposure, opiates produce long-term adaptations in both roles in drug reinforcement mechanisms. Also, unlike
regions, which oppose these acute effects. In the VTA, there is a the LC, it is less clear how these NAc cells are influenced
gross reduction in the size and, presumably, functioning of these
by their many inputs (e.g., VTA, prefrontal cortex, andneurons, which would oppose their activation by acute opiate expo-
amygdala) and how the outputs of the cells modify neu-sure. In the NAc, there is an up-regulation of the cAMP pathway,
ral circuits to regulate drug reinforcement and relatedwhich would oppose acute opiate inhibition of this pathway. Upon
removal of the opiate, these adaptations would lead to impairment behaviors. Future studies are needed to identify the spe-
in mesolimbic dopamine function,which could contribute to an aver- cific cell types in the NAc wherein up-regulation of the
sive state during withdrawal. cAMP pathway and other adaptations occur and how
these adaptations alter the functioning of these neurons
as well as the neural circuits in which they operate.
effects of opiates remains unknown (Wise, 1990; Koob, Adaptations in the VTA
1992). Nevertheless, the intensity and duration of these The changes elicited by chronic opiate exposure in the
acute actions of opiates, which would mediate a drug VTA are more complex. Chronic drug treatment induces
ªhigh,º far exceed the activation of the VTA±NAc that higher levels of tyrosine hydroxylase (the rate-limiting
occurs under normal conditions. This opioid-mediated enzyme in the biosynthesis of dopamine) and of specific
activation could elicit compensatory adaptations in VTA glutamate receptor subunits in this region (Nestler et
and NAc neurons to counter or impair the acute reactiv- al., 1993; Fitzgerald et al., 1996). Moreover, there appear
ity of these systems (Figure 2). Such adaptations could to be major structural adaptations, perhaps even neural
underlie motivational dependence by causing deficient injury, within this brain region. Chronic opiate exposure,
VTA±NAc function and thereby an aversive state during including self-administered heroin, decreases levels of
periods of drug withdrawal, changes alleviated by fur- neurofilament proteins and increases levels of glial fibril-
ther drug exposure. lary acidic protein specifically in this brain region. As
Despite considerable effort, it has not been possible would be expected, the reduction in neurofilament pro-
to fully account for alterations in VTA±NAc functioning, teins is associated with impaired axoplasmic transport
or the related behavioral phenomena, at the level of from the VTA to the NAc as well as with a reduction in
neurotransmitters and receptors (Koob, 1992; Self and the mean size of individual VTA dopamine neurons (Self
Nestler, 1995). There is some consensus that levels of and Nestler, 1995; Sklair-Tavron et al., 1995, Soc. Neu-
extracellular dopamine in the NAc, as measured by in rosci., abstract). Studies of the chronic actions of opi-
vivo microdialysis, may be diminished during early ates on the physiological activity of the VTA are needed
phases of opiate withdrawal and potentiated during later to complement these findings. Nevertheless, the ob-
phases, but little is known about themolecular and cellu- served adaptations are consistent with a gross impair-
lar adaptations that might underlie such phenomena. ment of VTA dopamine neurons, which, like up-regula-
Similarly, consistent changes in opioid or dopamine re- tion of the cAMP pathway in the NAc, can be viewed
ceptors following long-term opiate exposure have not as a compensatory response to acute opiate activation
of the cells (Figure 2). Such impairment in VTA functionbeen observed. In contrast, as with studies of opiate
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could then contribute to motivational dependence and ways that go far beyond regulation of endogenous opi-
oid peptides and opioid receptors or other neurotrans-an aversive state during opiate withdrawal.
mitter receptor systems. Increasing evidence supportsNeurotrophic Factors and Opiate Dependence
a role for adaptations in the cAMP pathway as one im-The nature of opiate-induced neural plasticity observed
portant molecular mechanism of opiate tolerance andin the VTA suggests a potential role for neurotrophic
dependence. Adaptations in many other signaling path-factors in these phenomena. Neurotrophic factors, al-
ways are also likely to be involved. One example isthough studied originally for their role in neural growth
opiate regulation of the neurotrophin±ERK signalingand development, are now known to regulate signal
cascade and its possible role in mediating some of thetransduction and neuronal viability in the fully differenti-
long-term effects of opiates on the brain. Opiate-ated adult brain. Indeed, recent studies have demon-
induced changes in the structural features of VTA dopa-strated that certain neurotrophic factors can pharmaco-
mine neurons further highlight the complex types oflogically modify opiate action in the mesolimbic
adaptations that are elicited in the brain by chronic drugdopamine system (Berhow et al., 1995). Administration
exposures. Indeed, these structural changes lend sup-of brain-derived neurotrophic factor (BDNF) or related
port to growing evidence for neural plasticity in the brainneurotrophins, directly into the VTA, both prevents and
that is detectable at theanatomical level. The availabilityreverses some of the effects that opiates elicit in this
of accurate animal models of opiate addiction enablebrain region (e.g., induction of tyrosine hydroxylase and
the exploration of these various mechanisms of neuralglial fibrillary acidic protein and structural changes in
plasticity within functional and clinically relevant con-VTA dopamine neurons). Intra-VTA infusions of BDNF
texts.also attenuate up-regulation of the cAMP pathway ob-
served in the NAc.
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